MRK Summary

  1. NYSE
  2. >
  3. MRK
TickerMRK
DescriptionMERCK & CO INC
Merck & Co., Inc. engages in the provision of health solutions through its prescription medicines, vaccines, biologic therapies, animal health, and consumer care products. It operates through the following segments: Pharmaceutical, Animal Health, Healthcare Services, and Alliances. The Pharmaceutical segment includes human health pharmaceutical and vaccine products. The Animal Health segment discovers, develops, manufactures, and markets animal health products, such as pharmaceutical and vaccine products, for the prevention, treatment and control of disease in livestock and companion animal species. The Healthcare Services segment offers services and solutions that focus on engagement, health analytics, and clinical services to improve the value of care delivered to patients. The Alliances segment includes results from the company's relationship with AstraZeneca LP related to sales of Nexium and Prilosec. The company was founded in 1891 and is headquartered in Kenilworth, NJ.
ExchangeNYSE
TypeStock
SectorHealthcare
Employees71,000
Next Earnings DateOctober 27th, 2020
IV28.560622%
IV Percentile76th
IV Rank30.28%
IV Skew12.353377
IV Skew Percentile72nd
IV Skew SentimentBearish
Option Volume11,316
Volume9,238,640
Price$78.07
Previous Close$78.27
52-Week High$92.64
52-Week Low$65.25
50-Day Moving Avg.$83.12
200-Day Moving Avg.$80.89
10-Day Avg. Volume8,435,626
20-Day Avg. Volume7,990,180
30-Day Avg. Volume8,243,829
3-Month Avg. Volume8,096,939
PE19.04843
EPS$4.13
Outstanding Shares2,529,240,000
Float2,527,123,026
Market Capitalization$198,975,395,000
CurrencyUSD
UpdatedOctober 21st, 2020